Lupin Limited Acquires HuminsulinⓇ: What This Means for the Indian Market

▫️Lupin Limited’s acquisition of HuminsulinⓇ from Eli Lilly in India is indeed a strategic move that aligns with its commitment to providing affordable healthcare solutions. By transitioning from a marketing partner to the brand owner, Lupin can leverage its robust distribution network, R&D capabilities, and market expertise to enhance access to advanced insulin options. ▫️Given … Read more

Indian Pharma Companies Continue to Excel with USFDA Approvals 2024!

♦️The Indian pharmaceutical sector has been a key player in global healthcare, and recent data from the USFDA shows just how impactful Indian companies are in delivering affordable and high-quality generic medicines to the world. ♦️This achievement underscores India’s pivotal role in the global pharmaceutical ecosystem. Indian companies have become synonymous with quality, cost-efficiency, and … Read more

Exit mobile version